ALFA Filings
Every announcement, straight from the exchange
Every Anuh Pharma other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
5 announcements
Anuh Pharma Ltd filed the quarterly compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, as issued by its RTA.
Anuh Pharma Ltd. promoters withdrew their application for reclassification from 'Promoter Group' to 'Public' category. They will continue to remain part of the Promoter Group.
Anuh Pharma Ltd notified the exchange about dispatching physical letters to shareholders regarding the 66th Annual General Meeting and the availability of the FY 2025-26 Annual Report.
Anuh Pharma Ltd submitted its Annual Secretarial Compliance Report for the financial year 2025-2026. The report confirms overall regulatory adherence with no new non-compliances observed.
Anuh Pharma Ltd submitted its compliance certificate under Regulation 74(5) for the quarter ended March 31, 2026. The Registrar and Share Transfer Agent confirmed that no dematerialization requests for equity shares were received during the period.